Atopic dermatitis (AD) is usually described by patients as an unceasing itch-scratch cycle. Continuous itching can impact in the quality of life of patients and their families.
The itch-scratch cycle alongside disrupted sleep patterns can take its toll on study, work and overall social well being. DermaSilk, new to Australia, represents an innovative approach to the management of eczema. DermaSilk is a range of therapeutic undergarments made of specially modified silk permanently bonded to a broad spectrum antimicrobial (AEM 5772/5).
The silk used in DermaSilk is hypoallergenic, made from 100% sericin-free fibres and knitted in an open weave to optimise thermo-regulating function. The permanently bonded antimicrobial in DermaSilk is durable, effective, non-migrating to the skin or to the environment and non washable.
The efficacy of DermaSilk has been documented in a number of peer reviewed studies.
“The use of DermaSilk has a significant beneficial effect in AD because of the
Research has shown that silk fibres are significantly superior to cotton fibres.
THE HYPOALLERGENIC SILK
THE ANTIMICROBIAL MODE OF ACTION
“The antimicrobial acts by destruction of the bacteria cell membrane via ion exchange”1
The technology used in DermaSilk ensures that the microbe does not become resistant to the antimicrobial agent, providing long lasting protection for the skin.
The antimicrobial in DermaSilk has been proven to be effective in a wide range of bacteria and fungi, including but not limited to the following:
For further clinical information on the efficacy of DermaSilk, see the recent published articles.